Elisabeth Lange

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

Barbara Eichhorst, Anna‐Maria Fink, Jasmin Bahlo et al. · The Lancet Oncology · 2016 · 622 citations

Medicine, Immunology, Oncology +14

Cortical Thickness and Subcortical Volumes in Schizophrenia and Bipolar Disorder

Lars M. Rimol, Cecilie B. Hartberg, Ragnar Nesvåg et al. · Biological Psychiatry · 2010 · 470 citations

Medicine, Neuroscience, Psychiatry +14

Cortical Volume, Surface Area, and Thickness in Schizophrenia and Bipolar Disorder

Lars M. Rimol, Ragnar Nesvåg, Don Hagler et al. · Biological Psychiatry · 2012 · 345 citations

Medicine, Neuroscience, Psychiatry +15

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

Richard F. Schlenk, Daniela Weber, Walter Fiedler et al. · Blood · 2018 · 288 citations · Full text

Medicine, Oncology, Pharmacology +12

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia

Wolfgang Bethge, Jolanta Dengler, M Bornhäuser et al. · Leukemia · 2012 · 230 citations

Medicine, Hematology, Oncology +14